Yqgr Former Conservative councillor faces a trial over ldquo;offensive rdquo; tweet about Sadiq Khan
Tuesday 28 February 2017 7:24 amGreggs hikes dividend as healthy food sales help boost profitsBy: Caitlin MorrisonShareFacebookShare on FacebookXShare on TwitterLinkedInShare on LinkedInWhatsAppShare on WhatsAppEmailShare on EmailAdd as a preferredsource on GoogleGreggs has reported a jump in sales for last year, and has hiked its dividend after growing profits ndash;but the baker is looking at job cuts as it aims for greater supply chain efficiency.The figuresTotal sales rose seven per cent to pound;894.2
stanley thermobecher m from pound;835.7m
owala deutschland , while company-managed like-for-like sales which excludes franchises went up 4.2 per cent.Pre-tax profit increased to pound;75.1m from pound;73m.The bakery chain increased its dividend by 8.4 per cent to 31p per share, compared with 28.6p per share last year. Shares in Greggs dropped two per cent at the open.Why it s interestingGreggs said its Balanced Choices range now accounts for over 10 per cent of total sales, vindicating its decision last summer to go into the healthier food market.However, the group warned that it is facing a period of greater economic uncertainty and increased pressure from cost inflation in the short term, and as such, there will be job losses in its manufacturing operations.The company said it hadcommunicated proposals for
stanley quencher supply chain changesto staff at each of its sites last month, including the planned impact of consolidating our manufacturing operations . Overall our expansion plans will create thousands of new role Aqqu Rio helped by sale of Alcan
Monday 30 September 2013 3:04 amAstra Zeneca given new ovarian cancer drug go-ahead by regulatorBy: Harriet GreenShareFacebookShare on FacebookXShare on TwitterLinkedInShare on Linke
stanley uk dInWhatsAppShare on WhatsAppEmailShare on EmailAdd as a preferredsource on GoogleBiopharmaceutical company Astra Zeneca has had a marketing authorisation application accepted for a new ovarian cancer drug.The oral drug, Olaparib, kills cancer cells and has the potential to be used to
stanley drink bottle treat a range of tumours. The granting of the application by the European Medicines Agency EMA means that it can be put on the market, having gone through a series of trials.Ovarian cancer is the eighth most commonly diagnosed cancer in women and the seventh biggest cause of cancer death among women globally. Treatments beyond the platinum-based chemotherapy currently used are vital for the 60 per cent of ovarian cancer patients whose cancer has spread by the time of diagnosis, as their five-year survival rate is less than 50 per cent.Olaparib is made with a key enzyme in one of the DNA repair pathways i
owala n human cells. Share this articleFacebookXLinkedInWhatsAppEmailSimilarly tagged content: SectionsNewsCategoriesCity A.M. ContentTrending ArticlesLabour will regret the Rentersrsquo; Rights ActUK at lsquo;greatest riskrsquo; of jet fuel shortage as flights to be cancelledJet fuel shortage looms as government scrambles to secure suppliesAfter Santanderrsquo TSB takeover ndash; who are the top players in UK banki
